In last trading session, Axogen Inc (NASDAQ:AXGN) saw 0.35 million shares changing hands with its beta currently measuring 1.03. Company’s recent per share price level of $17.25 trading at $0.09 or 0.52% at ring of the bell on the day assigns it a market valuation of $764.93M. That closing price of AXGN’s stock is at a discount of -21.74% from its 52-week high price of $21.00 and is indicating a premium of 67.83% from its 52-week low price of $5.55. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.57 million shares which gives us an average trading volume of 530.63K if we extend that period to 3-months.
For Axogen Inc (AXGN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.14. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.02 in the current quarter.
Axogen Inc (NASDAQ:AXGN) trade information
Upright in the green during last session for gaining 0.52%, in the last five days AXGN remained trading in the red while hitting it’s week-highest on Friday, 03/14/25 when the stock touched $17.25 price level, adding 4.17% to its value on the day. Axogen Inc’s shares saw a change of 4.67% in year-to-date performance and have moved -2.71% in past 5-day. Axogen Inc (NASDAQ:AXGN) showed a performance of -3.04% in past 30-days. Number of shares sold short was 1.85 million shares which calculate 3.87 days to cover the short interests.
Axogen Inc (AXGN) estimates and forecasts
This year revenue growth is estimated to rise 15.83% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 48.79M for the same. And 6 analysts are in estimates of company making revenue of 53.44M in the next quarter. Company posted 41.38M and 47.91M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 21.24% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 115.62% while estimates for its earnings growth in next 5 years are of 77.74%.
Axogen Inc (NASDAQ:AXGN)’s Major holders
Insiders are in possession of 5.50% of company’s total shares while institution are holding 81.94 percent of that, with stock having share float percentage of 86.71%. Investors also watch the number of corporate investors in a company very closely, which is 81.94% institutions for Axogen Inc that are currently holding shares of the company. ARROWMARK COLORADO HOLDINGS LLC is the top institutional holder at AXGN for having 5.12 million shares of worth $37.04 million. And as of 2024-06-30, it was holding 11.7048 of the company’s outstanding shares.
The second largest institutional holder is FIRST LIGHT ASSET MANAGEMENT, LLC, which was holding about 3.34 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.6499 of outstanding shares, having a total worth of $24.21 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.31 shares of worth $22.59 million or 2.95% of the total outstanding shares. The later fund manager was in possession of 1.16 shares on Dec 31, 2024 , making its stake of worth around $19.94 million in the company or a holder of 2.61% of company’s stock.
